Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 1:00 pm Purchase |
2024-12-31 | 13G | Fennec Pharmaceuticals Inc. FENC |
Solas Capital Management, LLC | 2,250,919 8.200% |
327,383 (+17.02%) |
Filing History |
| 2025-02-14 12:06 pm Sale |
2024-12-31 | 13G | Fennec Pharmaceuticals Inc. FENC |
DG Capital Management, LLC | 1,114,692 4.100% |
-407,512 (-26.77%) |
Filing History |
| 2024-11-14 1:58 pm Purchase |
2024-09-30 | 13G | Fennec Pharmaceuticals Inc. FENC |
Solas Capital Management, LLC | 1,923,536 7.000% |
545,023 (+39.54%) |
Filing History |
| 2024-11-12 7:38 pm Purchase |
2024-09-30 | 13G | Fennec Pharmaceuticals Inc. FENC |
DG Capital Management, LLC | 1,522,204 5.500% |
105,748 (+7.47%) |
Filing History |
| 2024-06-27 4:43 pm Purchase |
2024-05-14 | 13G | Fennec Pharmaceuticals Inc. FENC |
DG Capital Management, LLC | 1,416,456 5.200% |
1,416,456 (New Position) |
Filing History |
| 2024-02-14 10:47 am Purchase |
2023-12-31 | 13G | Fennec Pharmaceuticals Inc. FENC |
Solas Capital Management, LLC | 1,378,513 5.200% |
1,378,513 (New Position) |
Filing History |
| 2023-02-14 3:35 pm Purchase |
2022-12-31 | 13G | Fennec Pharmaceuticals Inc. FENC |
Sonic GP LLC | 2,578,134 9.800% |
2,578,134 (New Position) |
Filing History |
| 2022-02-14 09:08 am Sale |
2021-12-31 | 13G | Fennec Pharmaceuticals Inc. FENC |
Sonic Fund II L.P. | 2,469,880 9.500% |
-25,873 (-1.04%) |
Filing History |
| 2022-02-11 10:08 am Sale |
2021-12-31 | 13G | Fennec Pharmaceuticals Inc. FENC |
AVORO CAPITAL ADVISORS LLC | 1,200,000 4.600% |
-470,000 (-28.14%) |
Filing History |
| 2021-02-16 3:44 pm Purchase |
2020-04-30 | 13G | Fennec Pharmaceuticals Inc. FENC |
Sonic Fund II L.P. | 2,495,753 9.700% |
2,495,753 (New Position) |
Filing History |
| 2021-02-12 4:00 pm Purchase |
2020-12-31 | 13G | Fennec Pharmaceuticals Inc. FENC |
Southpoint Master Fund, LP | 4,077,214 15.800% |
80,000 (+2.00%) |
Filing History |
| 2021-02-12 08:01 am Purchase |
2020-12-31 | 13G | Fennec Pharmaceuticals Inc. FENC |
AVORO CAPITAL ADVISORS LLC | 1,670,000 6.500% |
564,001 (+50.99%) |
Filing History |
| 2020-05-04 5:22 pm Purchase |
2020-04-30 | 13D | Fennec Pharmaceuticals Inc. FENC |
SIGMA TAU FINANZIARIA SPA | 3,993,694 16.200% |
768,000 (+23.81%) |
Filing History |